- Country: USA
- Summary: Plasmax Plasma Concentration System Plasma Kits Notice Of Intent to Sole Source
- UST Ref No: 133645308
- Deadline: 16 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36C24426Q0175
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Draft (Pre Decisional)
VHAPG Part 806.3 OFOC Page 1 of 4
Revision: 04 Effective Date: 12/15/25
Acquisition ID#: 36C24426AP0796
DEPARTMENT OF VETERANS AFFAIRS
Justification and Approval (J&A)
For
Other Than Full and Open Competition (SAT)
Acquisition Plan Action ID: 36C244-26-AP-0796
Contracting Activity: Department of Veterans Affairs, VISN 04, Lebanon VA Medical Center 1700 South Lincoln Avenue, Lebanon PA 17042. Transaction Number 595-26-1-050-0731
Nature and/or Description of the Action Being Approved: The Lebanon VA has a new firm fixed price requirement for the Plasmax Plasma Kits. The Plasmax concentration system is a specialized device designed to produce a fully autologous plasma concentrate with elevated fibrinogen concentration, which is optimal for haemostasis. It consists of two parts: the GPS III Separator, which produces leukocyte-rich platelet-rich plasma (L-PRP) from a small sample of the patient s own blood, and the Plasmax Concentrator, which produces autologous fibrinogen-rich platelet-poor plasma concentrate (PPPc) using polyacrylamide beads to remove excess water. This system is designed to eliminate concerns regarding pooled blood sources, as it produces an autologous output from the Plasmax Plasma Concentration System.
Description of Supplies/Services Required to Meet the Agency s Needs: The Plasmax Plasma Concentration System is comprised of two distinct parts, the GPS III Separator and the Plasmax Concentrator. The GPS III Separator produces leukocyte-rich platelet-rich plasma (L-PRP) from a small sample of the patient s own blood. The Plasmax Concentrator produces autologous fibrinogen-rich platelet-poor plasma concentrate (PPPc) utilizing polyacrylamide beads to remove excess water.
Features of the system include:
Outputs up to 10 cc of rapidly polymerizing autologous plasma concentrate3
Outputs up to 3 or 6 cc of PRP, depending on which GPS III kit is being used
Produces both outputs in less ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPlasmax Plasma Concentration System Plasma Kits Notice Of Intent to Sole Source - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Plasmax Plasma Concentration System Plasma Kits Notice Of Intent to Sole Source. This tender is published on USARFP under UST Ref No: 133645308 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-16.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
